Procurement Summary
Country : USA
Summary : Deep Proteomic Profile of Serum Samples with Proteograph Proteomics Platform
Deadline : 24 Jul 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 104014416
Document Ref. No. : 75N95024Q00360
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
(ii) The solicitation number is 75N95024Q00360 and the solicitation is issued as a request for quotation (RFQ).
This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; and FAR Part 12—Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold.
(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2024-05, with effective date 05/22/2024.
(iv) The associated NAICS code 621511 and the small business size standard is $41.5 million. This requirement is full and open with no set-aside restrictions.
(v) This requirement is for the following services:
The contractor shall complete a full service project from serum sample to LC-MS data on the proteomic platform and analysis with key insights for 91 samples. Data analysis will include a detailed standard report after an initial 60-minute project consultation and with dedicated 10 hours of data analysis assistance. Analysis must be completed on the Seer Proteograph Product Suite.
(vi) Please see Statement of Work attached.
(vii) The Government anticipates award of a firm fixed-price purchase order for this acquisition, and the anticipated period of performance is six (6) months. The contractor shall provide services at the following Government sites, as well as the contractor-s site: NIH Biomedical Research Center, 251 Bayview Blvd., Room 010C214, Baltimore, MD 21224.
(viii)...
Active Contract Opportunity Notice ID 75N95024Q00360 Related Notice 75N95024Q00360 Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier NATIONAL INSTITUTES OF HEALTH Office NATIONAL INSTITUTES OF HEALTH NIDA
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Jul 10, 2024 12:02 pm EDT
Original Date Offers Due: Jul 24, 2024 09:00 am EDT
Inactive Policy: 15 days after date offers due
Original Inactive Date: Aug 08, 2024
Initiative: None
Classification
Original Set Aside:
Product Service Code: Q301 - REFERENCE LABORATORY TESTING
NAICS Code: 621511 - Medical Laboratories
Place of Performance: Baltimore, MD 21224 USA
Documents
Tender Notice
D--Statement-of-Work.pdf
D--Invoicing-Instructions-With-IPP-3-23.pdf
D--FAR-52.222-52-May-2014.pdf
D--FAR-52.212-5-May-2024-FILLABLE-5-22-2024.pdf
D--FAR-52.204-26-Oct-2020.pdf